4.4 Article

Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome P450 46A1

Journal

Publisher

INT UNION CRYSTALLOGRAPHY
DOI: 10.1107/S0907444908004046

Keywords

-

Funding

  1. NEI NIH HHS [EY018383, R01 EY018383] Funding Source: Medline
  2. NIA NIH HHS [K02 AG024336, AG 024336] Funding Source: Medline
  3. NIGMS NIH HHS [GM 62882, GM031001, R01 GM031001, R01 GM031001-27, R01 GM062882] Funding Source: Medline

Ask authors/readers for more resources

Human cytochrome P450 46A1 (CYP46A1) is one of the key enzymes in cholesterol homeostasis in the brain. The crystallization and heavy-atom structure solution of an active truncated CYP46A1 in complex with the high-affinity substrate analogue cholesterol-3-sulfate (CH-3S) is reported. The 2.6 A structure of CYP46A1-CH-3S was solved using both anion and cation heavy-atom salts. In addition to the native anomalous signal from the haem iron, an NaI anion halide salt derivative and a complementary CsCl alkali-metal cation salt derivative were used. The general implications of the use of halide and alkali-metal quick soaks are discussed. The importance of using isoionic strength buffers, the titration of heavy-atom salts into different ionic species and the role of concentration are considered. It was observed that cation/anion-binding sites will occasionally overlap, which could negatively impact upon mixed RbBr soaks used for multiple anomalous scatterer MAD (MMAD). The use of complementary cation and anion heavy-atom salt derivatives is a convenient and powerful tool for MIR(AS) structure solution.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available